One-time complete revascularization vs. staged PCI in multivessel Coronary Artery Disease during a pharmaco-invasive STEMI strategy

Clicks: 3
ID: 327546
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #283 of 291 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 291 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The optimal timing of complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD) undergoing a pharmaco-invasive strategy remains uncertain. Aim and Objectives To compare one-time complete revascularization during the index PCI with staged PCI regarding clinical outcomes, resource utilization, contrast-induced nephropathy (CIN), and short-term major adverse cardiovascular events (MACE) in STEMI patients with MVD treated using a pharmaco-invasive strategy. Methods This prospective randomized comparative study enrolled 112 adult patients with acute STEMI and MVD who underwent successful fibrinolysis followed by PCI. Patients were randomized to one-time complete revascularization during the index procedure (Group A, n = 56) or culprit-only PCI followed by staged non-culprit PCI within one month (Group B, n = 56). Outcomes included total hospitalization time, total treatment costs, CIN within 72 h, echocardiographic parameters, and 3-month MACE. Results Baseline characteristics and reperfusion timelines were comparable between groups. One-time complete revascularization significantly reduced total hospitalization time (2.9 ± 1.1 vs. 5.0 ± 1.4 days; P < 0.0001) and total treatment costs (median 46 514 vs. 70 517 EGP; P < 0.001). Left ventricular ejection fraction and serum creatinine were similar between groups at baseline and at 3 months. Wall motion score index was significantly lower in the one-time revascularization group at baseline (1.7 ± 0.3 vs. 1.8 ± 0.17; P = 0.032) and at 3 months (1.4 ± 0.28 vs. 1.5 ± 0.24; P = 0.045). Angina-related hospitalization at 3 months occurred less frequently in the one-time revascularization group (14.3 vs. 53.6%; P < 0.001), while other in-hospital complications and MACE components did not differ significantly between groups. Conclusions In patients with STEMI and multivessel coronary artery disease treated with a pharmaco-invasive strategy, one-time complete revascularization reduced hospitalization duration, healthcare costs, and angina-related readmissions without increasing short-term adverse cardiovascular events. These findings support one-time complete revascularization as an effective and safe strategy in appropriately selected patients.
Reference Key
openalex_W7207601812 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ahmed Gaafar, Ahmed Rashed Basyouny, Magdy Ismail, Moustafa Mokarrab, Amany Ibrahim
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag109.005
URL
https://doi.org/10.1093/eurheartjsupp/suag109.005
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.